158 related articles for article (PubMed ID: 1698020)
1. The prevention of cytomegalovirus disease in renal transplantation.
Davis CL
Am J Kidney Dis; 1990 Sep; 16(3):175-88. PubMed ID: 1698020
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of cytomegalovirus infections in renal transplants].
Rondeau E; Peraldi MN; Kanfer A; Sraer JD
Nephrologie; 1991; 12(4):189-92. PubMed ID: 1660570
[TBL] [Abstract][Full Text] [Related]
3. Studies evaluating high-dose acyclovir, intravenous immune globulin, and cytomegalovirus hyperimmunoglobulin for prophylaxis against cytomegalovirus in kidney transplant recipients.
Dickinson BI; Gora-Harper ML; McCraney SA; Gosland M
Ann Pharmacother; 1996 Dec; 30(12):1452-64. PubMed ID: 8968459
[TBL] [Abstract][Full Text] [Related]
4. Reduction by combination prophylactic therapy with CMV hyperimmune globulin and acyclovir of the risk of primary CMV disease in renal transplant recipients.
Nicol DL; MacDonald AS; Belitsky P; Lee S; Cohen AD; Bitter-Suermann H; Lowen J; Whalen A
Transplantation; 1993 Apr; 55(4):841-6. PubMed ID: 8386404
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic Transplantation.
Rea F; Potena L; Yonan N; Wagner F; Calabrese F
Transplantation; 2016 Mar; 100 Suppl 3(Suppl 3):S19-26. PubMed ID: 26900991
[TBL] [Abstract][Full Text] [Related]
6. A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients.
Flechner SM; Avery RK; Fisher R; Mastroianni BA; Papajcik DA; O'Malley KJ; Goormastic M; Goldfarb DA; Modlin CS; Novick AC
Transplantation; 1998 Dec; 66(12):1682-8. PubMed ID: 9884259
[TBL] [Abstract][Full Text] [Related]
7. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients.
Zamora MR; Fullerton DA; Campbell DN; Leone S; Diercks MJ; Fisher JH; Badesch DB; Grover FL
Transplant Proc; 1994 Oct; 26(5 Suppl 1):49-51. PubMed ID: 7940974
[TBL] [Abstract][Full Text] [Related]
8. Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients.
Vrtovec B; Thomas CD; Radovancevic R; Frazier OH; Radovancevic B
J Heart Lung Transplant; 2004 Apr; 23(4):461-5. PubMed ID: 15063406
[TBL] [Abstract][Full Text] [Related]
9. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial.
Snydman DR; Werner BG; Dougherty NN; Griffith J; Rubin RH; Dienstag JL; Rohrer RH; Freeman R; Jenkins R; Lewis WD; Hammer S; O'Rourke E; Grady GF; Fawaz K; Kaplan MM; Hoffman MA; Katz AT; Doran M;
Ann Intern Med; 1993 Nov; 119(10):984-91. PubMed ID: 8214995
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation.
Ranganathan K; Worley S; Michaels MG; Arrigan S; Aurora P; Ballmann M; Boyer D; Conrad C; Eichler I; Elidemir O; Goldfarb S; Mallory GB; Mogayzel PJ; Parakininkas D; Solomon M; Visner G; Sweet SC; Faro A; Danziger-Isakov L
J Heart Lung Transplant; 2009 Oct; 28(10):1050-6. PubMed ID: 19782286
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview.
Grossi P; Mohacsi P; Szabolcs Z; Potena L
Transplantation; 2016 Mar; 100 Suppl 3(Suppl 3):S1-4. PubMed ID: 26900989
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of CMV hyperimmune globulin prophylaxis in 377 heart transplant recipients.
Kocher AA; Bonaros N; Dunkler D; Ehrlich M; Schlechta B; Zweytick B; Grimm M; Zuckermann A; Wolner E; Laufer G
J Heart Lung Transplant; 2003 Mar; 22(3):250-7. PubMed ID: 12633691
[TBL] [Abstract][Full Text] [Related]
15. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study.
Fleming JN; Taber DJ; Weimert NA; Nadig S; McGillicuddy JW; Bratton CF; Baliga PK; Chavin KD
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28921781
[TBL] [Abstract][Full Text] [Related]
16. Prevention of cytomegalovirus infection in the pediatric renal transplant recipient.
Hibberd PL; Rubin RH
Pediatr Nephrol; 1991 Jan; 5(1):112-7. PubMed ID: 1851031
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection.
DesJardin JA; Gibbons L; Cho E; Supran SE; Falagas ME; Werner BG; Snydman DR
J Infect Dis; 1998 Dec; 178(6):1783-6. PubMed ID: 9815234
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.
Turgeon N; Fishman JA; Basgoz N; Tolkoff-Rubin NE; Doran M; Cosimi AB; Rubin RH
Transplantation; 1998 Dec; 66(12):1780-6. PubMed ID: 9884276
[TBL] [Abstract][Full Text] [Related]
19. Prevention of cytomegalovirus disease in renal allograft recipients.
Balfour HH
Scand J Infect Dis Suppl; 1991; 80():88-93. PubMed ID: 1725064
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection and renal transplantation.
Metselaar HJ; Weimar W
J Antimicrob Chemother; 1989 Jun; 23 Suppl E():37-47. PubMed ID: 2550411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]